trimethyloxamine has been researched along with clopidogrel in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fu, W; Hu, X; Jiang, H; Ma, R; Yang, J; Zhang, J | 1 |
Ge, PX; Ji, JZ; Jiang, LP; Li, YF; Mi, QY; Tai, T; Xie, HG; Zhu, T | 1 |
2 other study(ies) available for trimethyloxamine and clopidogrel
Article | Year |
---|---|
TMAO: a potential mediator of clopidogrel resistance.
Topics: Animals; Biomarkers; Blood Platelets; Clopidogrel; Coronary Artery Disease; Disease Models, Animal; Drug Resistance; Male; Methylamines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Rats | 2021 |
Choline and trimethylamine N-oxide impair metabolic activation of and platelet response to clopidogrel through activation of the NOX/ROS/Nrf2/CES1 pathway.
Topics: Acetylcysteine; Activation, Metabolic; Animals; Choline; Clopidogrel; Male; Mice; NF-E2-Related Factor 2; Reactive Oxygen Species | 2023 |